Dr. Kayser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1051 Riverside Drive
3100 Suite
New York, NY 10032
Summary
- I am a psychiatrist and clinical researcher focused on identifying and testing novel therapeutic strategies to treat symptoms of obsessive-compulsive disorder (OCD) and anxiety. I am particularly interested in the brain’s endocannabinoid system, its role in the pathophysiology underlying OCD and anxiety disorders, and its potential as a treatment target for these conditions.
After graduating from Yale University with a BA in psychology/behavioral neuroscience, I obtained my medical degree from Georgetown University School of Medicine. I then completed residency in psychiatry and an NIMH T32 research fellowship in affective, anxiety, and related disorders at Columbia University Medical Center and New York State Psychiatric Institute.
I currently serve as Medical Director of the Center for OCD and Related Disorders, where I treat patients with OCD and anxiety disorders as a study psychiatrist, help to coordinate the Center’s various clinical research projects, and supervise research assistants, residents, and fellows.
Education & Training
- New York-Presbyterian HospitalPost-Doctoral Fellowship, 2018 - 2021
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 2014 - 2018
- Georgetown University School of MedicineClass of 2014
- Yale UniversityB.A., Psychology/Behavioral Neuroscience, 2004 - 2008
Certifications & Licensure
- NY State Medical License 2015 - 2024
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder Start of enrollment: 2022 Mar 01
Publications & Presentations
PubMed
- 9 citationsResilience predicts positive mental health outcomes during the COVID-19 pandemic in New Yorkers with and without obsessive-compulsive disorder.Dianne M Hezel, Amy M Rapp, Michael G Wheaton, Reilly R Kayser, Sarah V Rose
Journal of Psychiatric Research. 2022-06-01 - 2 citationsPipeline in Jeopardy-Challenges in Developing Patient-Oriented Interventions Researchers in Psychiatry and Opportunities for Action.Reilly R Kayser, Melissa Arbuckle, H Blair Simpson
JAMA Psychiatry. 2022-02-01 - 7 citationsPatterns of Cannabis Use Among Individuals with Obsessive-Compulsive Disorder: Results from an Internet Survey.Reilly R. Kayser, Meredith S Senter, Rebecca Tobet, Marissa Raskin, Sapana R. Patel
Journal of Obsessive-Compulsive and Related Disorders. 2021-07-01
Books/Book Chapters
Press Mentions
- Cannabis Hyperemesis Syndrome: 5 Scientific Answers to "Scromiting" QuestionsAugust 5th, 2021
- Can CBD Help OCD??February 5th, 2021
- Cannabinoids Could Help Treat OCD, Researchers SuggestAugust 21st, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: